vs
DigitalOcean Holdings, Inc.（DOCN）与Tarsus Pharmaceuticals, Inc.（TARS）财务数据对比。点击上方公司名可切换其他公司
DigitalOcean Holdings, Inc.的季度营收约是Tarsus Pharmaceuticals, Inc.的1.6倍（$242.4M vs $151.7M），DigitalOcean Holdings, Inc.净利率更高（10.6% vs -5.5%，领先16.1%），Tarsus Pharmaceuticals, Inc.同比增速更快（128.4% vs 18.3%），DigitalOcean Holdings, Inc.自由现金流更多（$31.1M vs $13.0M），过去两年Tarsus Pharmaceuticals, Inc.的营收复合增速更高（134.4% vs 14.5%）
DigitalOcean Holdings, Inc.是美国跨国科技企业及云服务提供商，总部位于美国科罗拉多州布鲁姆菲尔德，在全球布局15个数据中心，面向开发者、初创企业及中小微企业提供稳定易用的云基础设施即服务平台，助力各类技术团队高效开展业务。
Tarsus Pharmaceuticals是一家处于后期临床阶段的生物制药公司，专注于眼科、皮肤科等专科领域创新疗法的研发和商业化，主打产品针对蠕形螨睑缘炎、玫瑰痤疮等未被充分诊断的常见病症，核心市场为美国。
DOCN vs TARS — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $242.4M | $151.7M |
| 净利润 | $25.7M | $-8.4M |
| 毛利率 | 58.7% | — |
| 营业利润率 | 16.0% | -5.3% |
| 净利率 | 10.6% | -5.5% |
| 营收同比 | 18.3% | 128.4% |
| 净利润同比 | 40.5% | 63.8% |
| 每股收益（稀释后） | $0.23 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $242.4M | $151.7M | ||
| Q3 25 | $229.6M | $118.7M | ||
| Q2 25 | $218.7M | $102.7M | ||
| Q1 25 | $210.7M | $78.3M | ||
| Q4 24 | $204.9M | $66.4M | ||
| Q3 24 | $198.5M | $48.1M | ||
| Q2 24 | $192.5M | $40.8M | ||
| Q1 24 | $184.7M | $27.6M |
| Q4 25 | $25.7M | $-8.4M | ||
| Q3 25 | $158.4M | $-12.6M | ||
| Q2 25 | $37.0M | $-20.3M | ||
| Q1 25 | $38.2M | $-25.1M | ||
| Q4 24 | $18.3M | $-23.1M | ||
| Q3 24 | $32.9M | $-23.4M | ||
| Q2 24 | $19.1M | $-33.3M | ||
| Q1 24 | $14.1M | $-35.7M |
| Q4 25 | 58.7% | — | ||
| Q3 25 | 59.6% | — | ||
| Q2 25 | 59.9% | — | ||
| Q1 25 | 61.4% | — | ||
| Q4 24 | 57.1% | — | ||
| Q3 24 | 60.2% | — | ||
| Q2 24 | 61.0% | — | ||
| Q1 24 | 60.7% | — |
| Q4 25 | 16.0% | -5.3% | ||
| Q3 25 | 19.6% | -12.2% | ||
| Q2 25 | 16.3% | -21.6% | ||
| Q1 25 | 17.9% | -33.5% | ||
| Q4 24 | 15.9% | -36.8% | ||
| Q3 24 | 12.4% | -52.3% | ||
| Q2 24 | 11.6% | -81.6% | ||
| Q1 24 | 6.2% | -136.5% |
| Q4 25 | 10.6% | -5.5% | ||
| Q3 25 | 69.0% | -10.6% | ||
| Q2 25 | 16.9% | -19.8% | ||
| Q1 25 | 18.1% | -32.1% | ||
| Q4 24 | 8.9% | -34.8% | ||
| Q3 24 | 16.6% | -48.7% | ||
| Q2 24 | 9.9% | -81.6% | ||
| Q1 24 | 7.7% | -129.4% |
| Q4 25 | $0.23 | $-0.17 | ||
| Q3 25 | $1.51 | $-0.30 | ||
| Q2 25 | $0.39 | $-0.48 | ||
| Q1 25 | $0.39 | $-0.64 | ||
| Q4 24 | $0.21 | $-0.57 | ||
| Q3 24 | $0.33 | $-0.61 | ||
| Q2 24 | $0.20 | $-0.88 | ||
| Q1 24 | $0.15 | $-1.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $254.5M | $417.3M |
| 总债务越低越好 | $1.3B | $72.4M |
| 股东权益账面价值 | $-28.7M | $343.4M |
| 总资产 | $1.8B | $562.2M |
| 负债/权益比越低杠杆越低 | — | 0.21× |
8季度趋势，按日历期对齐
| Q4 25 | $254.5M | $417.3M | ||
| Q3 25 | $236.6M | $401.8M | ||
| Q2 25 | $387.7M | $381.1M | ||
| Q1 25 | $360.4M | $407.9M | ||
| Q4 24 | $428.4M | $291.4M | ||
| Q3 24 | $439.9M | $317.0M | ||
| Q2 24 | $443.1M | $323.6M | ||
| Q1 24 | $419.1M | $298.5M |
| Q4 25 | $1.3B | $72.4M | ||
| Q3 25 | $1.3B | $72.3M | ||
| Q2 25 | — | $72.1M | ||
| Q1 25 | — | $72.0M | ||
| Q4 24 | $1.5B | $71.8M | ||
| Q3 24 | — | $71.7M | ||
| Q2 24 | — | $71.6M | ||
| Q1 24 | — | $29.9M |
| Q4 25 | $-28.7M | $343.4M | ||
| Q3 25 | $-69.6M | $335.1M | ||
| Q2 25 | $-175.2M | $332.6M | ||
| Q1 25 | $-210.7M | $342.5M | ||
| Q4 24 | $-203.0M | $224.5M | ||
| Q3 24 | $-211.7M | $237.5M | ||
| Q2 24 | $-253.8M | $252.2M | ||
| Q1 24 | $-286.1M | $275.2M |
| Q4 25 | $1.8B | $562.2M | ||
| Q3 25 | $1.7B | $534.6M | ||
| Q2 25 | $1.7B | $495.0M | ||
| Q1 25 | $1.6B | $500.8M | ||
| Q4 24 | $1.6B | $377.0M | ||
| Q3 24 | $1.5B | $376.3M | ||
| Q2 24 | $1.5B | $376.8M | ||
| Q1 24 | $1.5B | $349.3M |
| Q4 25 | — | 0.21× | ||
| Q3 25 | — | 0.22× | ||
| Q2 25 | — | 0.22× | ||
| Q1 25 | — | 0.21× | ||
| Q4 24 | — | 0.32× | ||
| Q3 24 | — | 0.30× | ||
| Q2 24 | — | 0.28× | ||
| Q1 24 | — | 0.11× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $57.3M | $19.3M |
| 自由现金流经营现金流 - 资本支出 | $31.1M | $13.0M |
| 自由现金流率自由现金流/营收 | 12.8% | 8.6% |
| 资本支出强度资本支出/营收 | 10.8% | 4.2% |
| 现金转化率经营现金流/净利润 | 2.23× | — |
| 过去12个月自由现金流最近4个季度 | $180.5M | $-22.3M |
8季度趋势，按日历期对齐
| Q4 25 | $57.3M | $19.3M | ||
| Q3 25 | $95.8M | $18.3M | ||
| Q2 25 | $92.4M | $-29.4M | ||
| Q1 25 | $64.1M | $-20.7M | ||
| Q4 24 | $71.3M | $-22.2M | ||
| Q3 24 | $73.4M | $-8.7M | ||
| Q2 24 | $71.3M | $-14.4M | ||
| Q1 24 | $66.7M | $-37.8M |
| Q4 25 | $31.1M | $13.0M | ||
| Q3 25 | $88.0M | $16.3M | ||
| Q2 25 | $59.3M | $-30.4M | ||
| Q1 25 | $2.1M | $-21.2M | ||
| Q4 24 | $26.1M | $-22.3M | ||
| Q3 24 | $16.0M | $-8.9M | ||
| Q2 24 | $39.5M | $-15.4M | ||
| Q1 24 | $23.0M | $-38.0M |
| Q4 25 | 12.8% | 8.6% | ||
| Q3 25 | 38.3% | 13.8% | ||
| Q2 25 | 27.1% | -29.6% | ||
| Q1 25 | 1.0% | -27.1% | ||
| Q4 24 | 12.7% | -33.5% | ||
| Q3 24 | 8.1% | -18.6% | ||
| Q2 24 | 20.5% | -37.8% | ||
| Q1 24 | 12.5% | -137.5% |
| Q4 25 | 10.8% | 4.2% | ||
| Q3 25 | 3.4% | 1.6% | ||
| Q2 25 | 15.2% | 1.0% | ||
| Q1 25 | 29.4% | 0.8% | ||
| Q4 24 | 22.1% | 0.1% | ||
| Q3 24 | 28.9% | 0.6% | ||
| Q2 24 | 16.6% | 2.5% | ||
| Q1 24 | 23.6% | 0.6% |
| Q4 25 | 2.23× | — | ||
| Q3 25 | 0.60× | — | ||
| Q2 25 | 2.50× | — | ||
| Q1 25 | 1.68× | — | ||
| Q4 24 | 3.91× | — | ||
| Q3 24 | 2.23× | — | ||
| Q2 24 | 3.73× | — | ||
| Q1 24 | 4.72× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOCN
| Scalers | $84.3M | 35% |
| Scalers Plus | $69.9M | 29% |
| Builders | $64.1M | 26% |
| Learners Testers And Other | $24.1M | 10% |
TARS
暂无分部数据
